Leonard S, Arbogast D, Geyer D, Jones C, Sinensky M
Proc Natl Acad Sci U S A. 1986 Apr;83(7):2187-9. doi: 10.1073/pnas.83.7.2187.
A series of hybrids between primary human cells and a Chinese hamster somatic cell mutant (Mev-1), defective in expression of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase [(S)-3-hydroxy-3-methylglutaryl-CoA acetoacetyl-CoA-lyase (CoA-acetylating, EC 4.1.3.5], has been prepared that complements the mutant defect. A technique based on differential sensitivity of this enzyme activity to inhibition by magnesium ion is described that allows the discrimination of expression of human and hamster HMG-CoA synthase in these hybrids. The results indicate a structural gene defect in expression of HMG-CoA synthase activity in Mev-1 cells. Segregation of human chromosomes that do not possess the complementing marker have allowed the assignment of human HMG-CoA synthase activity to chromosome 5. This is the second demonstrably transcriptionally regulated enzyme of cholesterologenesis to be assigned to chromosome 5, the other being HMG-CoA reductase.
已制备出一系列原代人细胞与中国仓鼠体细胞突变体(Mev-1)的杂种细胞,该突变体在3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)合酶[(S)-3-羟基-3-甲基戊二酰辅酶A乙酰乙酰辅酶A裂解酶(辅酶A乙酰化,EC 4.1.3.5)]的表达上存在缺陷,这些杂种细胞可弥补该突变体的缺陷。描述了一种基于该酶活性对镁离子抑制的差异敏感性的技术,该技术可用于区分这些杂种细胞中人源和仓鼠源HMG-CoA合酶的表达。结果表明Mev-1细胞中HMG-CoA合酶活性的表达存在结构基因缺陷。不具有互补标记的人类染色体的分离已将人HMG-CoA合酶活性定位于5号染色体。这是第二种被明确证明受转录调控的胆固醇生物合成酶被定位于5号染色体,另一种是HMG-CoA还原酶。